New mexico tuberculosis (TB) elimination project - the mission of the new mexico department of health(nmdoh) is to ensure the health equity, work with partners to promote health and well-being, and…

New mexico tuberculosis (TB) elimination project - the mission of the new mexico department of health(nmdoh) is to ensure the health equity, work with partners to promote health and well-being, and improve health outcomes for all people in new mexico. The tuberculosis (TB) program is one of eight programs within the communicable disease bureau (CDB) in the public health division (PHD). As a centralized health department and state program, the TB program provides comprehensive medical and nursing case management services for persons with TB disease and TB infection. The program provides programmatic oversight, TB nurse consultation, education, training, and resources to 52 local health offices in 33 counties. Services are provided at no charge to patients served, including case management and medications. This ensures access to quality, best-practice care that reduces barriers to support completion of effective treatment. Elimination of TB in new mexico is promoted by implementing three priority strategies for controlling and preventing TB, as recommended by the advisory council for the elimination of tuberculosis (acet). These are: 1) identifying and fully treating persons who have active TB disease, 2) finding and screening persons who are contacts to TB cases to determine if they are infected with mycobacterium tuberculosis or have TB disease, and providing appropriate treatment, and 3) targeting populations at high-risk for infection and disease to detect infected persons and provide TB infection (TBI) therapy when appropriate to prevent progression to active TB. This funding application will ensure resources to continue to meet state and CDC goals for TB elimination. Funding for prevention and control (p & c) and for public health laboratory strengthening will allow for continued and new activities that will be measured by evaluation of progress toward short-term and intermediate outcomes. Progress toward these outcomes will lead to a decreased TB incidence overall, with a focus on reducing incidence and improving health outcomes among populations at higher risk and those disproportionately affected by TB disease and TB infection.